When should you deactivate implanted cardiac devices?

May 2007
Hospice Management Advisor;May2007, Vol. 12 Issue 5, p55
The article presents the views of U.S. physicians on when to deactivate implanted cardiac devices among hospice patients. James Kirkpatrick states that there is a lack of national rules that would aid physicians in deciding the existence of implants. Jennifer Ballantine on her study expresses that if such devices prolong the suffering of a patient, interfering the function of the device is needed. Nathan Goldstein states implants should be removed if adverse effects exist.


Related Articles

  • When should you deactivate implanted cardiac devices?  // Medical Ethics Advisor;Apr2007, Vol. 23 Issue 4, p41 

    The article discusses the deactivation of implanted cardiac devices. A survey of hospices in Denver reveals that physicians have varied reaction on deactivating cardiac devices. According to James Kirkpatrick, an echocardiologist in Pennsylvania, there is a lack of national guidelines that would...

  • New device detects changes in heart….  // Medical Device Daily;4/29/2011, Vol. 15 Issue 83, Special section p1 

    The article offers information on the AngelMed Guardian implantable heart monitor device for heart attack patients.

  • Detroit center implants CoreValve.  // Medical Device Daily;3/3/2011, Vol. 15 Issue 42, p3 

    The article reports on the completion of the first two transcatheter aortic valve implants (TAVI) by the Detroit Medical Center Cardiovascular Institute (CVI) in Michigan.

  • A healthy combination. Teague, Paul E. // Design News;6/4/2001, Vol. 57 Issue 11, p13 

    Editorial. Comments on an implantable heart-monitoring device from Medtronic that could transmit information to Internet sites. Forecast on the device's public release; Significance of medical devices having Internet capabilities; Application to drug-based therapy.

  • Significant improvement of myocardial function following cardiac support device implantation: Illustration by two-dimensional strain. Serri, Karim; Labrousse, Louis; Reant, Patricia; Lafitte, Stephane; Roudaut, Raymond // European Journal of Echocardiography;Dec2006, Vol. 7 Issue 6, p473 

    Abstract: Cardiac support devices (CSD) offer a new therapeutic alternative to patients with end-stage refractory heart failure and severe left ventricle (LV) dilatation. Passive mechanical constraint has been shown to reduce LV dilatation as well as to improve LV function and patient symptoms....

  • Percutaneous Vertebroplasty in a Broken Vertebral Titanium Implant (Titanium Mesh Cage). Bierry, G.; Buy, X.; Mohan, P.; Cupelli, J.; Steib, J. P.; Gangi, A. // CardioVascular & Interventional Radiology;Jul/Aug2006, Vol. 29 Issue 4, p706 

    We report the case of a percutaneous consolidation of a broken vertebral implant (Surgical Titanium Mesh Implants; DePuy Spine, Raynham, MA, USA) by vertebroplasty. Four years after anterior spondylectomy with cage implantation and stabilization with posterior instrumentation, the patient was...

  • Ventricular assist devices. Chauhan, Sandeep // Annals of Cardiac Anaesthesia;Oct-Dec2013, Vol. 16 Issue 4, p257 

    The author focuses on the implantation of left ventricular assist devices (LVAD). A study published within the issue, about patients with LVADs who underwent endoscopy procedures for gastrointestinal bleeding, is referenced. Factors for medical personnel to consider before performing surgery on...

  • SynCardia Total Artificial Heart. Copeland, Jack G. // Texas Heart Institute Journal;2013, Vol. 40 Issue 5, p587 

    The article evaluates the SynCardia temporary Total Artificial Heart (TAH-t) from SynCardia Systems Inc.

  • Initial Clinical Experience with the HeartMate II Axial-Flow Left Ventricular Assist Device. Frazier, O. H.; Gemmato, Courtney; Myers, Timothy J.; Gregoric, Igor D.; Radovancevic, Brano; Loyalka, Pranav; Kar, Biswajit // Texas Heart Institute Journal;2007, Vol. 34 Issue 3, p275 

    The redesigned HeartMate[R] II, an axial-flow left ventricular assist device, is simpler, smaller, and easier to operate than are pulsatile pumps. These design characteristics should make the HeartMate II more reliable and durable and broaden the eligible population base. We implanted the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics